Evidence map›Paper›PMID 38071208›Full record

ArticleScientific reports2023

Multicenter study to describe viral etiologies, clinical profiles, and outcomes of hospitalized children with severe acute respiratory infections, Egypt 2022.

Amr Kandeel, Manal Fahim, Ola Deghedy, Wael H Roshdy, Mohamed K Khalifa, Rabeh El Shesheny, Ahmed Kandeil, Saly Wagdy, Amel Naguib, Salma Afifi and 1 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Unveiling the Multifaceted Capabilities of EndophyticPharmaceuticals (Basel, Switzerland) · 2024
    Article
  16. A comprehensive review ofFrontiers in medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Amr KandeelPreventive Sector, Ministry of Health and Population, Cairo, Egypt.
Manal FahimPreventive Sector, Ministry of Health and Population, Cairo, Egypt.
Ola DeghedyPreventive Sector, Ministry of Health and Population, Cairo, Egypt. olasalah664@yahoo.com.
Wael H RoshdyCentral Public Health Laboratories, Ministry of Health and Population, Cairo, Egypt.
Mohamed K KhalifaCentre of Scientific Excellence for Influenza Viruses, National Research Centre, Dokki, Giza, 12622, Egypt.
Rabeh El SheshenyCentre of Scientific Excellence for Influenza Viruses, National Research Centre, Dokki, Giza, 12622, Egypt.
Ahmed KandeilCentre of Scientific Excellence for Influenza Viruses, National Research Centre, Dokki, Giza, 12622, Egypt.
Saly WagdyCentral Public Health Laboratories, Ministry of Health and Population, Cairo, Egypt.
Amel NaguibCentral Public Health Laboratories, Ministry of Health and Population, Cairo, Egypt.
Salma AfifiConsultant Ministry of Health and Population, Cairo, Egypt.
Khaled AbdelghaffarMinistry of Health and Population, Cairo, Egypt.
Ministry of Health and Population · EGNational Research Centre · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In late 2022, severe acute respiratory infections (SARI) surveillance reported an abrupt increase in non-COVID-19 infections among children after three years of drastic reductions. Signals of increased absenteeism due to respiratory symptoms among primary and preparatory school children were detected by Event-Based Surveillance. We conducted a hospital-based survey of children who were admitted with SARI to identify the causative pathogen(s) and estimate the burden of infection. A survey was conducted among children < 16 years in 21 referral hospitals in the three governorates with the highest SARI rates. Patients' demographics, clinical symptoms, and severity were collected from medical records using a line list. Patients were swabbed and tested for a panel of 33 respiratory pathogens by RT-PCR at the Central Laboratory in Cairo. Descriptive data analysis was performed for demographic data. Patients' characteristics were compared by causative agents' clinical picture and severity using Chi2 with a p < 0.05 significance. Overall, 317 patients were enrolled, 58.3% were ≤ 1 year of age, 61.5% were males. Of 229 (72.7%) of positively tested patients, viruses caused 92.1% including RSV 63.8%, Rhinovirus 10.0%, Influenza 9.2%, Adenovirus 5.2%, and 1.3% co-infected with two viruses. Bacteria caused 3.5% of cases and 4.4% had mixed viral-bacterial infections. Rhinovirus was the most common cause of death among children with SARI, followed by RSV (8.7% and 1.4%), whereas influenza and Adenovirus did not result in any deaths. Patients with viral-bacterial infections are more likely to be admitted to ICU and die at the hospital than bacterial or viral infections (60% and 20% vs. 31.8% and 1.9% vs. 12.5% and 12.5%, p < 0.001). Viruses particularly RSV are the leading cause of SARI causing significant health problem among children < 16 years in Egypt. Bacterial on top of viral infection can worsen disease courses and outcomes. Studies are required to estimate the SARI burden accurately among Egyptian children and a comprehensive approach tailored to Egypt is necessary to reduce its burden.

Indexed as

Adenoviridae InfectionsBacterial InfectionsInfluenza, HumanPneumoniaRespiratory Tract InfectionsVirus DiseasesAdolescentChildChild, HospitalizedChild, PreschoolEgyptFemaleHumansInfantMaleRhinovirus

Identifiers

PMID38071208
PMCPMC10710477
OpenAlexW4389504562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.